Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetFlex: Trimetazidine in ALS
NCT04788745Phase 2Completed
- Sponsor
- The University of Queensland
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of trimetazidine in amyotrophic lateral sclerosis (ALS), sponsored by The University of Queensland. Started Jun 2021; status: completed.
02
Drugs
trimetazidine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04788745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788745.